Organ Involvement With Acute GVHD in the Two Study Arms
. | Ciprofloxacin + Metronidazole . | Ciprofloxacin . | P Value3-150 . |
---|---|---|---|
Skin3-151 | |||
0 | 18 (26) | 14 (21) | |
1 | 8 (12) | 5 (8) | |
2 | 29 (43) | 19 (29) | <.03 |
3 | 10 (15) | 18 (27) | |
4 | 3 (4) | 10 (15) | |
Liver3-151 | |||
0 | 57 (84) | 43 (65) | |
1 | 1 (1) | 7 (11) | |
2 | 2 (3) | 1 (2) | <.01 |
3 | 1 (1) | 8 (12) | |
4 | 7 (10) | 7 (11) | |
Intestinal tract3-151 | |||
0 | 60 (88) | 46 (70) | |
1 | 0 | 2 (3) | |
2 | 0 | 3 (5) | <.02 |
3 | 4 (6) | 2 (3) | |
4 | 4 (6) | 13 (20) | |
No. of involved organs3-151 | |||
0 | 16 (24) | 14 (21) | |
1 | 41 (60) | 26 (39) | <.02 |
2 | 5 (7) | 9 (14) | |
3 | 6 (9) | 17 (26) | |
Grades of acute GVHD3-151 | |||
0 | 16 (24) | 14 (21) | |
I | 35 (51) | 19 (29) | |
II | 5 (7) | 12 (18) | <.04 |
III | 3 (4) | 6 (9) | |
IV | 9 (13) | 15 (23) |
. | Ciprofloxacin + Metronidazole . | Ciprofloxacin . | P Value3-150 . |
---|---|---|---|
Skin3-151 | |||
0 | 18 (26) | 14 (21) | |
1 | 8 (12) | 5 (8) | |
2 | 29 (43) | 19 (29) | <.03 |
3 | 10 (15) | 18 (27) | |
4 | 3 (4) | 10 (15) | |
Liver3-151 | |||
0 | 57 (84) | 43 (65) | |
1 | 1 (1) | 7 (11) | |
2 | 2 (3) | 1 (2) | <.01 |
3 | 1 (1) | 8 (12) | |
4 | 7 (10) | 7 (11) | |
Intestinal tract3-151 | |||
0 | 60 (88) | 46 (70) | |
1 | 0 | 2 (3) | |
2 | 0 | 3 (5) | <.02 |
3 | 4 (6) | 2 (3) | |
4 | 4 (6) | 13 (20) | |
No. of involved organs3-151 | |||
0 | 16 (24) | 14 (21) | |
1 | 41 (60) | 26 (39) | <.02 |
2 | 5 (7) | 9 (14) | |
3 | 6 (9) | 17 (26) | |
Grades of acute GVHD3-151 | |||
0 | 16 (24) | 14 (21) | |
I | 35 (51) | 19 (29) | |
II | 5 (7) | 12 (18) | <.04 |
III | 3 (4) | 6 (9) | |
IV | 9 (13) | 15 (23) |